Enforce Immediately In CBD Supplement Market, Industry Groups Suggest To FDA
FDA should go beyond warning letters to carry out inspections, import reviews and other actions on companies marketing CBD-containing supplements and foods, CHPA says. It and other consumer health trade groups urge agency to act immediately numerous businesses marketing products that could threaten public health.
You may also be interested in...
FDA’s second report to Congress on oversight of CBD market includes results from studies of whether products are mislabeled or adulterated, but also indicates throughout that more data are needed on safety of hemp-derived CBD ingredients used in myriad consumer health, cosmetic and food products already available.
US Wellness Market In 2019: Farm Bill Made Cultivating Cannabidiol Policy FDA's Main Course In Supplements
As HBW Insight looks back on notable US wellness market developments and events for the previous 12 months, we find that news in the CBD space from the FDA and the industry dominated the sector throughout 2019.
AHPA releases guidance for tea and infusion products on regulatory and liability implications as a result of increasing Prop 65 lawsuits; CHPA files citizen petition urging FDA to act on a CBD pathway; PEW pushes for stronger supplement oversight; and more.